Michael Connolly, MD
Sleep Medicine · Clanton, ALNPI 1669423554
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $819 and has fallen 92.9% since, to $58 in 2024. That places this record below the midpoint for sleep medicine clinicians in AL, where the typical reported total is $3,427.
Across 91 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$385
- Regeneron Healthcare Solutions, Inc.$253
- GSK$155
- Jazz Pharmaceuticals Inc.$149
- Harmony Biosciences LLC$112
- Boehringer Ingelheim$112
- plus $534 from 15 others
What the payments were for
- Food & beverage$1,700100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $385 |
| Regeneron Healthcare Solutions, Inc. | 11 | $253 |
| GSK | 10 | $155 |
| Jazz Pharmaceuticals Inc. | 8 | $149 |
| Harmony Biosciences LLC | 5 | $112 |
| Boehringer Ingelheim | 8 | $112 |
| Genentech USA, Inc. | 4 | $88 |
| Electromed, Inc. | 6 | $88 |
| Mylan Specialty L.p. | 3 | $59 |
| Philips North America LLC | 2 | $52 |
| Grifols USA, LLC | 2 | $48 |
| Amgen | 3 | $48 |
| Ardelyx, Inc. | 1 | $23 |
| Pfizer | 1 | $20 |
| Circassia Inc. | 1 | $19 |
| Abbott | 1 | $19 |
| Advanced Respiratory, Inc | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Pulmonx Corporation | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Merck | 1 | $12 |
How this compares
$1,700 in reported general payments places this provider in the 20th percentile of 28 sleep medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 112 | $83,894 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $10,454 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $9,354 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $6,504 |
| Modafinil | 61 | $6,198 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 136 | $5,314 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 127 | $4,743 |
| Varenicline Tartrate | 16 | $4,398 |
| Adderall XrDextroamphetamine/Amphetamine | 12 | $2,406 |
| Armodafinil | 12 | $1,290 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $1,095 |
| Methylphenidate Hcl | 11 | $564 |
| Eszopiclone | 20 | $367 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 11 | $225 |
| Trazodone Hcl | 45 | $211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $155 | $103,703152 claims |
| AstraZenecaSymbicort | $385 | $6,50417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 28 sleep medicine providers in Alabama.
Other sleep medicine in Clanton
- James RoyHuntsville$823K
- Michael LedetDaphne$795K
- Gordon WarnerCullman$100K
- James GeyerTuscaloosa$61K
- Ashwin AnanthFoley$57K
- Christopher HopeOpelika$32K
- Bahador TafazoliCullman$26K
- Erin OzgunBirmingham$16K
- Felix MorrisFlorence$15K
- Alan ThomasBirmingham$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.